Effects of acute renal failure on the pharmacokinetics of chlorzoxazone in rats

Drug Metabolism and Disposition

Volumn 31, Issue 6, 2003, Pages 776-784

  Moon, Young Jin ^a   Lee, Ae Kyung ^a   Chung, Hye Chin ^a   Kim, Eun Jung ^a   Kim, So Hee ^b   Lee, Duk Chul ^c   Lee, Inchul ^a,d   Kim, Sang Geon ^a   Lee, Myung Gull ^a  

^a Seoul National University   (South Korea)

^b Gangneung Wonju National University   (South Korea)

^c Mizmedi Hospital   (South Korea)

^d University of Ulsan   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; 6 HYDROXYCHLORZOXAZONE; CHLORPHENOTANE; CHLORZOXAZONE; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2B1; CYTOCHROME P450 2B2; CYTOCHROME P450 2C11; CYTOCHROME P450 2E1; CYTOCHROME P450 3A23; ETHYLENE DERIVATIVE; UNCLASSIFIED DRUG; URANYL NITRATE;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG TISSUE LEVEL; ENZYME ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER MICROSOME; MALE; NONHUMAN; NORTHERN BLOTTING; ORGAN WEIGHT; PRIORITY JOURNAL; RAT; TIME SERIES ANALYSIS;

ANIMALIA;

EID: 0038193617     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.31.6.776     Document Type: Article

References (53)

1. Biagini CP, Philpot RM, and Celier CM (1999) Nonsubstrate recognition site residues are involved in testosterone hydroxylation by cytochrome P450 CYP2C11. Arch Biochem Biophys 361:309-314.
2. Carriere V, Goasduff T, Ratanasavanh D, Morel F, Gautier JC, Guillouza A, Beaune P, and Berthou F (1993) Both cytochromes P450 2E1 and 1A1 are involved in the metabolism of chlorzoxazone. Chem Res Toxicol 6:852-857.
3. Chen L and Yang CS (1996) Effects of cytochrome P450 2E1 modulators on the pharmacokinctics of chlorzoxazone and 6-hydroxychlorzoxazone in rats. Life Sci 58:1575-1585.
4. Chiou WL (1978) Critical evaluation of potential error in pharmacokinetic studies using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve. J Pharmacokinet Biopharm 6:539-549.
5. Chiou WL (1979) New calculation method for mean apparent drug volume of distribution and application to rational dosage regimen. J Pharm Sci 68:1067-1069.
6. Chiou WL (1980) New calculation method of mean total body clearance of drugs and its application to rational regimens. J Pharm Sci 69:90-91.
7. Cho MK, Kim YG, Lee MG, and Kim SG (1999) Suppression of rat hepatic cytochrome P450s by protein-calorie malnutrition: complete or partial restoration by cysteine or methionine supplementation. Arch Biochem Biophys 372:150-158.
8. Chung HC, Kim SH, Lee MG, and Kim SG (2002) Increase in urea in conjunction with L-arginine metabolism in the liver leads to induction of cytochrome P450 2E1 (CYP2E1): the role of urea in CYP2E1 induction by acute renal failure. Drug Metab Dispos 30:739-742.
9. Conney AH and Burns JJ (1960) Physiological disposition and metabolic fate of chlorzoxazone (Paraflex) in man. J Pharmacol Exp Ther 128:340-343.
10. Davies B and Morris T (1993) Physiological parameters in laboratory animals and humans. Pharm Res (NY) 10:1093-1095.
11. Debri K, Boobis AR, Davies DS, and Edwards RJ (1995) Distribution and induction of CYP3A1 and CYP3A2 in rat liver and extrahepatic tissues. Biochem Pharmacol 50:2047-2056.
12. Desiraju RK, Renzi NL Jr, Nayak RK, and Ng KT (1983) Pharmacokinetics of chlorzoxazone in humans. J Pharm Sci 72:991-994.
13. Eatman FB, Colburn WA, Boxenbaum HG, Posmanter HN, Weinfeld RE, Ronfeld R, Weissman L, Moore JD, Gibaldi M, and Kaplan SA (1977) Pharmacokinetics of diazepam following multiple dose oral administration to healthy human subjects. J Pharmacokinet Biopharm 5:481-494.
14. Engineer MS, Ho DW, and Bodey GP Sr (1981) Comparison of vancomycin disposition in rats with normal and abnormal renal functions. Antimicrob Agents Chemother 20:718-722.
15. Fruncilto RJ, Swanson BN, Bernhard R, Marchion C, and Ferguson RK (1986) Effect of renal failure or biliary stasis on the pharmacokinetics of amiodarone in the rat. J Pharm Sci 75:150-154.
16. Frye RF and Stiff DD (1996) Determination of chlorzoxazone and 6-hydroxychlorzoxazone in human plasma and urine by high-performance liquid chromatography. J Chromatogr B 686:291-296.
17. Gibaldi M and Perrier D (1982) Pharmacokinetics, 2nd ed. Marcel Dekker, New York.
18. Gorski JC, Jones DR, Wrighton SA, and Hall SD (1997) Contribution of human CYP3A subfamily members to the 6-hydroxylation of chlorzoxazone. Xenobiotica 27:243-256.
19. Hoen PA, Bijsterbosch MK, van Berkel TJ, Vermeulen NPE, and Commandeur JNM (2001) Midazolam is a phenobarbital-like cytochrome p450 inducer in rats. J Pharmacol Exp Ther 299:921-927.
20. Kim HJ, Han KS, Chung Y-K, and Lee MG (1998) Pharmacokinetic changes of a new proton pump inhibitor, YJA-20379-8, after intravenous and oral administration to rats with uranyl nitrate-induced acute renal failure. Res Commun Mol Pathol Pharmacol 102:43-56.
21. Kim SG and Cho MK (1996) Expression of glutathione S-transferase Ya, Yba, Yb2, Yc1 and Yc2 and microsomal epoxide hydrolase gene by thiazole and benzothiadiazole. Biochem Pharmacol 52:1831-1841.
22. Kim SG, Chung HC, and Cho JY (1996a) Molecular mechanism for alkyl sulfide-modulated carbon tctrachloride-induced hepatotoxicity: the role of cytochrome P450 2E1, P450 2B and glutathione S-transferase expression. J Pharmacol Exp Ther 277:1058-1066.
23. Kim SG and Novak RF (1993) The induction of cytochrome P450 2E1 by nitrogen- and sulfur-containing heterocycles: expression and molecular regulation. Toxicol Appl Pharmacol 120:257-265.
24. Kim SH, Choi YM, and Lee MG (1993) Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition. J Pharmacokinet Biopharm 21:1-17.
25. Kim SH, Shim HJ, Kim WB, and Lee MG (1998) Pharmacokinetics of a new carbapenem, DA-1131, after intravenous administration to rats with uranyl nitrate-induced acute renal failure. Antimicrob Agents Chemother 42:1217-1221.
26. Kim YG, Yoon EJ, Yoon WH, Shim HJ, Lee SD, Kim WB, Yang J, and Lee MG (1996b) Pharmacokinetics of DA-125, a new anthracycline, after intravenous administration to uranyl nitrate-induced acute renal failure rats or protein-calorie malnutrition rats. Biopharm Drug Dispos 17:183-195.
27. Lee HJ, Paik WH, and Lee MG (1996) Pharmacokinetic and tissue distribution changes of adriamycin and adriamycinol after intravenous administration of adriamycin to uranyl nitrateinduced acute renal failure rats. Res Commun Mol Pathol Pharmacol 91:195-204.
28. Lee MG and Chiou WL (1983) Evaluation of potential causes for the incomplete bioavailability of furosemide: gastric first-pass metabolism. J Pharmacokinet Biopharm 11:623-640.
29. Lee Y-H, Lee M-H, and Shim C-K (1992) Decreased systemic clearance of diltiazem with increased hepatic metabolism in rats with uranyl nitrate-induced acute renal failure. Pharm Res (NY) 9:1599-1606.
30. Lee YH and Ku YS (1998) Effects of propranolol on the pharmacokinetics of cyclosporine after intravenous and oral administration to control rats and rats with uranyl nitrate-induced acute renal failure. Res Commun Mol Pathol Pharmacol 102:251-264.
31. Lee YH and Ku YS (1999) Effects of cyclosporin on the pharmacokinetics of propranolol after intravenous and oral administration to control rats and to rats with uranyl nitrate-induced acute renal failure. J Pharm Pharmacol 51:1149-1154.
32. Lewis DFV (1996) Substrate specificity and metabolism, in Cytochromes P450 Structure, Function and Mechanism, p 123. Taylor & Francis. Bristol, PA.
33. Li HC, Dehal SS, and Kupfer D (1995) Induction of the hepatic CYP2B and CYP3A enzymes by the proestrogenic pesticide methoxychlor and by DDT in the rat. Effects on methoxychlor metabolism. J Biochem Toxicol 10:51-61.
34. Lin JH and Lin TH (1988) Renal handling of drugs in renal failure: I. Differential effects of uranyl nitrate- and glycerol-induced acute renal failure on renal excretion of TEAB and PAH in rats. J Pharmacol Exp Ther 246:896-901.
35. Lineweaver H and Burk D (1934) The determination of enzyme dissociation constants. J Am Chem Soc 56:658-666.
36. Liu PT, Ioannides C, Shavila J, Symons AM, and Parke DV (1993) Effects of ether anaesthesia and fasting on various cytochromes P450 of rat liver and kidney. Biochem Pharmacol 45:871-877.
37. Liu JH, Malone RS, Stallings H, and Smith PC (1996) Influence of renal failure in rats on the disposition of salicyl acyl glucuronide and covalent binding of salicylate to plasma proteins. J Pharmacol Exp Ther 278:277-283.
38. Lowry OH, Rosebrough NG, Farr AL, and Randall RJ (1951) Protein measurement with Folin-phenol reagent. J Biol Chem 193:265-275.
39. Mahnke A, Strotkamp D, Roos PH, Hanstein WG, Chabot GG, and Nef P (1997) Expression and inducibility of cytochrome P450 3A9 (CYP3A9) and other members of the CYP3A subfamily in rat liver. Arch Biochem Biophys 337:62-68.
40. Mitruka BM and Rawnsley HM (1981) Clinical Biochemical and Hematological Reference Values in Normal Experimental Animal and Normal Humans, 2nd ed. Masson Publishing USA Inc., New York.
41. Ono S, Hatanaka T, Hotta H, Tsutsui M, Satoh T, and Gonzalez FJ (1995) Chlorzoxazone is metabolized by human CYP1A2 as well as by human CYP2E1. Pharmacogenetics 5:143-150.
42. Park JM, Moon C-H, and Lee MG (1996) Pharmacokinetic changes of methotrexate after intravenous administration to uranyl nitrate-induced acute renal failure rats. Res Commun Mol Pathol Pharmacol 93:353-362.
43. Park KJ, Yoon WH, Kim SH, Shin WG, and Lee MG (1998) Pharmacokinetic and pharmacodynamic changes of azosemide after intravenous and oral administration of azosemide to uranyl nitrate-induced acute renal failure rats. Biopharm Drug Dispos 19:141-146.
44. Peter R, Bocker R, Beaune PH, Iwasaki M, Guengerich FP, and Yang CS (1990) Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450 2E1. Chem Res Toxicol 3:566-573.
45. Puissant C and Houdebine LM (1990) An improvement of the single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Biotechniques 8:148-149.
46. Rekka E, Evdokimova E, Eeckhoudt S, Labar G, and Calderon PB (2002) Role of temperature on protein and mRNA cytochrome P450 3A (CYP3A) isozymes expression and midazolam oxidation by cultured rat precision-cut liver slices. Biochem Pharmacol 64:633-643.
47. Roberts BJ, Shoaf SE. Jeong KS, and Song BJ (1994) Induction of CYP2E1 in liver, kidney, brain and intestine during chronic ethanol administration and withdrawal: evidence that CYP2E1 possesses a rapid phase half-life of 6 hours or less. Biochem Biophys Res Commun 205:1064-1071.
48. Rockich K and Blouin R (1999) Effect of the acute-phase response on the pharmacokinetics of chlorzoxazone and cytochrome P-450 2E1 in vitro activity in rats. Drug Metab Dispos 27:1074-1077.
49. Shimada T, Tsumura F, and Tamazaki H (1999) Prediction of human liver microsomal oxidation of 7-ethoxycoumarin and chlorzoxazone with kinetic parameters of recombinant cytochrome P-450 enzymes. Drug Metab Dispos 27:1274-1280.
50. Sierra-Santoyo A, Hernandez M, Albores A, and Cebrian ME (2000) Sex-dependent regulation of hepatic cytochrome P-450 by DDT. Toxicol Sci 54:81-87.
51. Son IJ, Moon YJ, Lee MG, and Sohn YT (2000) Pharmacokinetic changes of intravenous tacrolimus in rats with uranyl nitrate-induced acute renal failure. Res Commun Mol Pathol Pharmacol 108:359-368.
52. Wilkinson GR and Shand DG (1975) Commentary: a physiological approach to hepatic drug clearance. Clin Pharmacol Ther 18:377-390.
53. You L, Chan SK, Bruce JM, Archibeque-Engle S, Casanova M, Corton JC, and Heck H (1999) Modulation of testosterone-metabolizing hepatic cytochrome P-450 enzymes in developing Sprague-Dawley rats following in utero exposure to p, p′-DDE. Toxicol Appl Pharmacol 158:197-205.